EUVIMEDEUVIMED entdecken
Open Access

Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View

Anna K Person, Brenda Crabtree-Ramirez, Ahra Kim, Valdiléa Veloso, Fernanda Maruri, Gilles Wandeler, Matthew Fox, Richard Moore, M John Gill, Darma Imran, Kinh Van Nguyen, Elizabeth Nalitya und 3 weitere

Clinical Infectious Diseases · 16.06.2023 · 76 (12) · 2116-2125

DOI: 10.1093/cid/ciad076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 23.02.2023. Verfasst von Anna K Person und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryptococcal meningitis (CM) is a major cause of morbidity and mortality in persons with human immunodeficiency virus (HIV; PWH). Little is known about CM outcomes and availability of diagnostic and treatment modalities globally.

Methods

In this retrospective cohort study, we investigated CM incidence and all-cause mortality in PWH in the International Epidemiology Databases to Evaluate AIDS cohort from 1996 to 2017. We estimated incidence using quasi-Poisson models adjusted for sex, age, calendar year, CD4 cell count (CD4), and antiretroviral therapy (ART) status. Mortality after CM diagnosis was examined using multivariable Cox models. A site survey from 2017 assessed availability of CM diagnostic and treatment modalities.

Results

Among 518 852 PWH, there were 3857 cases of CM with an estimated incidence of 1.54 per 1000 person-years. Mortality over a median of 2.6 years of post-CM diagnosis follow-up was 31.6%, with 29% lost to follow-up. In total, 2478 (64%) were diagnosed with CM after ART start with a median of 253 days from ART start to CM diagnosis. Older age (hazard [HR], 1.31 for 50 vs 35 years), lower CD4 (HR, 1.15 for 200 vs 350 cells/mm3), and earlier year of CM diagnosis (HR, 0.51 for 2015 vs 2000) were associated with higher mortality. Of 89 sites, 34% reported access to amphotericin B; 12% had access to flucytosine.

Conclusions

Mortality after CM diagnosis was high. A substantial portion of CM cases occurred after ART start, though incidence and mortality may be higher than reported due to ascertainment bias. Many sites lacked access to recommended CM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalHIV InfectionsHumansHIVRetrospective StudiesAmphotericin BAntifungal Agents

Stichwörter der Autor:innen

AIDSHIVcryptococcal meningitisglobal health

Substanzen

Amphotericin BAntifungal Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Intituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Global Health, Boston University, Boston, Massachusetts, USA.

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NCATS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Fogarty International Center

Zitieren

APA

Person, A. K., Crabtree-Ramirez, B., Kim, A., Veloso, V., Maruri, F., Wandeler, G., Fox, M., Moore, R., John Gill, M., Imran, D., Van Nguyen, K., Nalitya, E., Muyindike, W., Shepherd, B. E., & McGowan, C. C. (2023). Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clinical Infectious Diseases, 76(12), 2116-2125. https://doi.org/10.1093/cid/ciad076

Vancouver

Person AK, Crabtree-Ramirez B, Kim A, Veloso V, Maruri F, Wandeler G, et al. Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clinical Infectious Diseases. 2023;76(12):2116-2125. doi:10.1093/cid/ciad076

BibTeX
@article{Person2023,
  author = {Person, Anna K and Crabtree-Ramirez, Brenda and Kim, Ahra and Veloso, Valdiléa and Maruri, Fernanda and Wandeler, Gilles and Fox, Matthew and Moore, Richard and John Gill, M and Imran, Darma and Van Nguyen, Kinh and Nalitya, Elizabeth and Muyindike, Winnie and Shepherd, Bryan E and McGowan, Catherine C},
  title = {Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {12},
  pages = {2116--2125},
  doi = {10.1093/cid/ciad076}
}
Kostenlos starten →